Access cutting-edge breast cancer treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an early stage of breast cancer, can be an effective management of the disease. Participants will be asked to receive control hormonal therapy or an investigational hormonal therapy treatment. Participants will be asked to return for evaluation with MRI at three months and six months. Depending on the evaluation participants will have the optio
Sponsor: QuantumLeap Healthcare Collaborative
Check if you qualify for this breast cancer clinical trial in San Francisco, CA
If you're searching for breast cancer treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.